Google DeepMind Chairman Demis Hassabis outlines how cutting-edge AI models are transforming physical sciences, moving beyond digital text generation into biological and molecular simulation. Hassabis emphasizes that spin-off venture Isomorphic Labs is accelerating drug discovery by utilizing AlphaFold-inspired architectures to predict complex molecular interactions. The interview highlights DeepMind’s ongoing strategic focus on merging reinforc…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.